Please login to the form below
Data by
Top 25 pharma companies by cardiovascular sales
The rankings of the top 25 pharmaceutical companies in cardiovascular have been compiled from GlobalData's pharmaceutical revenue figures, which are based on sales of prescription medicines, including generics drugs. The rankings include figures for 2014, 2013, 2012 and 2011.
For ease of comparison the rankings, along with those for CNS, immunology, oncology, metabolic, global, US and Japan sales, are also displayed in the Top Pharma List 2012 infographic.
| # | Company | 2014 ($m) | 2013 ($m) | Growth ($m) | Growth (%) |
|---|---|---|---|---|---|
| 1 | AstraZeneca | 7657 | 7723 | -66 | -1 |
| 2 | Sanofi | 6620 | 6850 | -230 | -3 |
| 3 | Merck & Co. | 5230 | 5794 | -564 | -10 |
| 4 | Daiichi Sankyo | 4665 | 5205 | -540 | -10 |
| 5 | Pfizer | 4125 | 4603 | -478 | -10 |
| 6 | Novartis | 3948 | 5270 | -1322 | -25 |
| 7 | Bayer | 3868 | 2800 | 1068 | 38 |
| 8 | Takeda | 2457 | 2324 | 133 | 6 |
| 9 | Boehringer Ingelheim | 2418 | 3314 | -896 | -27 |
| 10 | Astellas | 2029 | 2105 | -76 | -4 |
| 11 | Actelion | 1958 | 1795 | 163 | 9 |
| 12 | Johnson & Johnson | 1522 | 864 | 658 | 76 |
| 13 | Shionogi | 1297 | 1512 | -215 | -14 |
| 14 | United Therapeutics | 1280 | 1107 | 173 | 16 |
| 15 | Bristol-Myers Squibb | 1193 | 635 | 558 | 88 |
| 16 | Gilead Sciences | 1105 | 969 | 136 | 14 |
| 17 | Otsuka | 846 | 817 | 29 | 4 |
| 18 | Roche | 796 | 728 | 68 | 9 |
| 19 | Lilly | 705 | 695 | 10 | 1 |
| 20 | The Medicines Company | 674 | 625 | 49 | 8 |
| # | Company | 2013 ($m) | 2012 ($m) | Growth ($m) | Growth (%) |
|---|---|---|---|---|---|
| 1 | AstraZeneca | 7723 | 8750 | -1027 | -12 |
| 2 | Novartis | 7215 | 7476 | -261 | -3 |
| 5 | Pfizer | 5735 | 8039 | -2304 | -29 |
| 3 | Sanofi | 6448 | 7337 | -889 | -12 |
| 4 | Merck & Co. | 6129 | 6576 | -447 | -7 |
| 6 | Daiichi Sankyo | 4053 | 4165 | -112 | -3 |
| 7 | Boehringer Ingelheim | 3926 | 3509 | 417 | 12 |
| 24 | Bristol-Myers Squibb | 635 | 3052 | -2417 | -79 |
| 12 | Astellas | 2006 | 2116 | -110 | -5 |
| 11 | GlaxoSmithKline | 2144 | 2266 | -122 | -5 |
| 18 | AbbVie | 953 | 2301 | -1348 | -59 |
| 10 | Takeda | 2500 | 2428 | 72 | 3 |
| 9 | Bayer | 2579 | 1887 | 692 | 37 |
| 14 | Shionogi | 1463 | 1476 | -13 | -1 |
| 16 | United Therapeutics | 1107 | 907 | 200 | 22 |
| 20 | Otsuka | 835 | 808 | 27 | 3 |
| 17 | Gilead Sciences | 969 | 783 | 186 | 24 |
| 22 | Dainippon Sumitomo Pharma | 719 | 755 | -36 | -5 |
| 23 | Mitsubishi Tanabe | 695 | 724 | -29 | -4 |
| 21 | Roche | 728 | 623 | 105 | 17 |
| 25 | The Medicines Company | 625 | 558 | 67 | 12 |
| 8 | Lilly | 3105 | 2823 | 282 | 10 |
| 13 | Actelion | 1794 | 1743 | 51 | 3 |
| 15 | Biogen Idec | 1126 | 1138 | -12 | -1 |
| 19 | Johnson & Johnson | 864 | 239 | 625 | 262 |
| # | Company | 2012 ($m) | 2011 ($m) | Growth ($m) | Growth (%) |
|---|---|---|---|---|---|
| 1 | AstraZeneca | 8750 | 9605 | -855 | -9 |
| 2 | Novartis | 7548 | 8405 | -857 | -10 |
| 3 | Pfizer | 7505 | 13437 | -5932 | -44 |
| 4 | Sanofi | 7337 | 8454 | -1117 | -13 |
| 5 | Merck & Co. | 6576 | 7174 | -598 | -8 |
| 6 | Daiichi Sankyo | 4165 | 4147 | 18 | 0 |
| 7 | Boehringer Ingelheim | 3509 | 3091 | 418 | 14 |
| 8 | Bristol-Myers Squibb | 3052 | 8039 | -4987 | -62 |
| 9 | Astellas | 2781 | 3011 | -230 | -8 |
| 10 | GlaxoSmithKline | 2377 | 2424 | -47 | -2 |
| 11 | AbbVie | 2301 | 2668 | -367 | -14 |
| 12 | Takeda | 2182 | 2713 | -531 | -20 |
| 13 | Bayer | 2153 | 1821 | 332 | 18 |
| 14 | Shionogi | 1476 | 1512 | -36 | -2 |
| 15 | Amgen | 950 | 808 | 142 | 18 |
| 16 | United Therapeutics | 907 | 741 | 166 | 22 |
| 17 | Otsuka | 854 | 834 | 20 | 2 |
| 18 | Gilead Sciences | 783 | 613 | 170 | 28 |
| 19 | Dainippon Sumitomo Pharma | 755 | 820 | -65 | -8 |
| 20 | Mitsubishi Tanabe | 724 | 777 | -53 | -7 |
| 21 | Roche | 623 | 511 | 112 | 22 |
| 22 | The Medicines Company | 558 | 485 | 73 | 15 |
| 23 | Merck KGaA | 488 | 552 | -64 | -12 |
| 24 | Lilly | 457 | 303 | 154 | 51 |
| 25 | Forest Laboratories | 455 | 348 | 107 | 31 |
Note: The 2013 ranking uses 2013 exchange rates for both its 2013 and 2012 values, to remove the effect of currency fluctuations. The 2012 ranking similarly uses 2012 exchange rates.
Data by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
Featured jobs
-
Programme Director
-
Salary TBC
- Director of Scientific and Editorial Services
-
Great salary and benefits - Circa 100K
-
Account Director
-
Salary TBC
- Junior - Mid Level Medical Copywriter, Healthcare Advertising Ag...
-
£30-35, 000 according to skills and experience
Subscribe to our email news alerts
PMHub
Kendle Healthcare
Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...
Latest intelligence
- AI’s potential in the pharma life cycle
- At a time that the future of life sciences is being hotly debated, the opportunity for the industry to refine and expand its role is an important one to take...
- OUTiCO Case Study - Product Launch
- POSITIVE FORMULARY SUCCESS WITHIN 8 MONTHS!...
- An insight into Multi-Channel Account Management
- At OUTiCO we often talk about moving away from traditional methods, embracing change, and offering an exceptional outsourcing service, but what does that mean day to day?...
Quick links
Infographics
